Jun 10, 2026Confidence A
Product0 evidence links
Guardian Bio product scope reviewed
Guardian Bio public product source reviewed for category placement and current operating focus.
No source evidence matched to this event.Dendritic cell-based platform for cancer therapy
Guardian Bio public product source reviewed for category placement and current operating focus.
No source evidence matched to this event.Guardian Bio public source reviewed for capital or strategic-status timeline signal.
No source evidence matched to this event.Guardian Bio official source reviewed for product scope, operating focus, and category placement.
Open sourceGuardian Bio public capital or strategic-status source reviewed for stage and timeline signal.
Open source